Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

• Status: Completed
• Trial end date: 2016-04-22
• Target enrollment: 0
• Participant gender: All

Summary

To collect the efficacy and safety information of Azithromycin IV related to their appropriate use in daily practice

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Azithromycin

Criteria

Inclusion Criteria:

• Male or Female patients who are prescribed Zithromac IV for pneumonia or pelvic inflammatory disease.

Exclusion Criteria:

• Subjects who have been prescribed Zithromac IV for pneumonia or pelvic inflammatory disease.